Cargando…
IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2
The proinflammatory cytokine Interleukin 17A (hereafter named IL–17A) or IL-17A producing cells are elevated in breast tumors environment and correlate with poor prognosis. Increased IL-17A is associated with ER(−) or triple negative tumors and reduced Disease Free Survival. However, the pathophysio...
Autores principales: | Cochaud, Stéphanie, Giustiniani, Jérôme, Thomas, Clémence, Laprevotte, Emilie, Garbar, Christian, Savoye, Aude-Marie, Curé, Hervé, Mascaux, Corinne, Alberici, Gilles, Bonnefoy, Nathalie, Eliaou, Jean-François, Bensussan, Armand, Bastid, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856404/ https://www.ncbi.nlm.nih.gov/pubmed/24316750 http://dx.doi.org/10.1038/srep03456 |
Ejemplares similares
-
IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells
por: Mombelli, Sarah, et al.
Publicado: (2015) -
The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway
por: Laprevotte, Emilie, et al.
Publicado: (2017) -
Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231
por: Garbar, Christian, et al.
Publicado: (2017) -
The Human Epidermal Growth Factor Receptor 2 Screening Tests for Breast Cancer Suggested by the New Updated Recommendation of the American Society of Clinical Oncology/College of American Pathologists Will Involve a Rise of the In-Situ Hybridization Tests for the European Laboratories of Pathology
por: Garbar, Christian, et al.
Publicado: (2014) -
Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape
por: Garbar, Christian, et al.
Publicado: (2018)